Logo image of MTD

METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

USA - NYSE:MTD - US5926881054 - Common Stock

1304 USD
+0.96 (+0.07%)
Last: 10/15/2025, 7:00:00 PM
1304 USD
0 (0%)
After Hours: 10/15/2025, 7:00:00 PM
Fundamental Rating

5

Overall MTD gets a fundamental rating of 5 out of 10. We evaluated MTD against 56 industry peers in the Life Sciences Tools & Services industry. MTD scores excellent on profitability, but there are some minor concerns on its financial health. MTD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year MTD was profitable.
MTD had a positive operating cash flow in the past year.
MTD had positive earnings in each of the past 5 years.
MTD had a positive operating cash flow in each of the past 5 years.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of MTD (24.40%) is better than 98.21% of its industry peers.
With an excellent Return On Invested Capital value of 39.61%, MTD belongs to the best of the industry, outperforming 98.21% of the companies in the same industry.
MTD had an Average Return On Invested Capital over the past 3 years of 41.86%. This is significantly above the industry average of 14.93%.
Industry RankSector Rank
ROA 24.4%
ROE N/A
ROIC 39.61%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

With an excellent Profit Margin value of 21.46%, MTD belongs to the best of the industry, outperforming 94.64% of the companies in the same industry.
In the last couple of years the Profit Margin of MTD has grown nicely.
MTD has a better Operating Margin (28.61%) than 100.00% of its industry peers.
MTD's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 59.94%, MTD is doing good in the industry, outperforming 78.57% of the companies in the same industry.
In the last couple of years the Gross Margin of MTD has remained more or less at the same level.
Industry RankSector Rank
OM 28.61%
PM (TTM) 21.46%
GM 59.94%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MTD has been reduced compared to 1 year ago.
The number of shares outstanding for MTD has been reduced compared to 5 years ago.
The debt/assets ratio for MTD is higher compared to a year ago.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MTD has an Altman-Z score of 10.26. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
MTD's Altman-Z score of 10.26 is amongst the best of the industry. MTD outperforms 92.86% of its industry peers.
MTD has a debt to FCF ratio of 2.58. This is a good value and a sign of high solvency as MTD would need 2.58 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.58, MTD belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.58
Altman-Z 10.26
ROIC/WACC3.85
WACC10.29%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MTD has a Current Ratio of 1.12. This is a normal value and indicates that MTD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MTD (1.12) is worse than 85.71% of its industry peers.
MTD has a Quick Ratio of 1.12. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
MTD's Quick ratio of 0.77 is on the low side compared to the rest of the industry. MTD is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.77
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

MTD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.37%, which is quite good.
The Earnings Per Share has been growing by 12.53% on average over the past years. This is quite good.
MTD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.10%.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.18% on average per year.
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%

3.2 Future

The Earnings Per Share is expected to grow by 9.10% on average over the next years. This is quite good.
MTD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.43% yearly.
EPS Next Y3.09%
EPS Next 2Y6.56%
EPS Next 3Y8.11%
EPS Next 5Y9.1%
Revenue Next Year3.3%
Revenue Next 2Y3.83%
Revenue Next 3Y4.33%
Revenue Next 5Y3.43%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20 40 60

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.88, MTD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 66.07% of the companies listed in the same industry.
MTD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.55.
MTD is valuated quite expensively with a Price/Forward Earnings ratio of 27.90.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 71.43% of the companies listed in the same industry.
MTD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.88
Fwd PE 27.9
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MTD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MTD is cheaper than 69.64% of the companies in the same industry.
MTD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTD is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.68
EV/EBITDA 23.58
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)10.31
PEG (5Y)2.54
EPS Next 2Y6.56%
EPS Next 3Y8.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (10/15/2025, 7:00:00 PM)

After market: 1304 0 (0%)

1304

+0.96 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners102.47%
Inst Owner Change0.06%
Ins Owners0.42%
Ins Owner Change2.98%
Market Cap26.86B
Analysts71.58
Price Target1342.35 (2.94%)
Short Float %3.49%
Short Ratio4.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.38%
Min EPS beat(2)2.78%
Max EPS beat(2)3.98%
EPS beat(4)4
Avg EPS beat(4)3.18%
Min EPS beat(4)1.02%
Max EPS beat(4)4.94%
EPS beat(8)6
Avg EPS beat(8)3.16%
EPS beat(12)10
Avg EPS beat(12)2.65%
EPS beat(16)14
Avg EPS beat(16)3.36%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)1.63%
Revenue beat(4)3
Avg Revenue beat(4)1.01%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)8
Avg Revenue beat(12)0.25%
Revenue beat(16)12
Avg Revenue beat(16)0.61%
PT rev (1m)0.9%
PT rev (3m)4.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.73%
EPS NY rev (1m)0.13%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 31.88
Fwd PE 27.9
P/S 6.95
P/FCF 31.68
P/OCF 28.23
P/B N/A
P/tB N/A
EV/EBITDA 23.58
EPS(TTM)40.9
EY3.14%
EPS(NY)46.73
Fwd EY3.58%
FCF(TTM)41.16
FCFY3.16%
OCF(TTM)46.2
OCFY3.54%
SpS187.7
BVpS-12.56
TBVpS-58.08
PEG (NY)10.31
PEG (5Y)2.54
Profitability
Industry RankSector Rank
ROA 24.4%
ROE N/A
ROCE 48.24%
ROIC 39.61%
ROICexc 40.71%
ROICexgc 70.2%
OM 28.61%
PM (TTM) 21.46%
GM 59.94%
FCFM 21.93%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.58
Debt/EBITDA 1.73
Cap/Depr 85.07%
Cap/Sales 2.69%
Interest Coverage 250
Cash Conversion 77.47%
Profit Quality 102.18%
Current Ratio 1.12
Quick Ratio 0.77
Altman-Z 10.26
F-Score7
WACC10.29%
ROIC/WACC3.85
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
EPS Next Y3.09%
EPS Next 2Y6.56%
EPS Next 3Y8.11%
EPS Next 5Y9.1%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%
Revenue Next Year3.3%
Revenue Next 2Y3.83%
Revenue Next 3Y4.33%
Revenue Next 5Y3.43%
EBIT growth 1Y4.27%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year5.77%
EBIT Next 3Y6.15%
EBIT Next 5Y6.84%
FCF growth 1Y-1.24%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y-1.81%
OCF growth 3Y2.14%
OCF growth 5Y9.92%